These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 34939932)
1. Inflammasome activation leads to cDC1-independent cross-priming of CD8 T cells by epithelial cell-derived antigen. Deets KA; Nichols Doyle R; Rauch I; Vance RE Elife; 2021 Dec; 10():. PubMed ID: 34939932 [TBL] [Abstract][Full Text] [Related]
2. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells. Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430 [TBL] [Abstract][Full Text] [Related]
3. cDC1 prime and are licensed by CD4 Ferris ST; Durai V; Wu R; Theisen DJ; Ward JP; Bern MD; Davidson JT; Bagadia P; Liu T; Briseño CG; Li L; Gillanders WE; Wu GF; Yokoyama WM; Murphy TL; Schreiber RD; Murphy KM Nature; 2020 Aug; 584(7822):624-629. PubMed ID: 32788723 [TBL] [Abstract][Full Text] [Related]
4. Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs Is Critical for T Cell Priming. McDaniel MM; Kottyan LC; Singh H; Pasare C Cell Rep; 2020 May; 31(5):107604. PubMed ID: 32375053 [TBL] [Abstract][Full Text] [Related]
6. Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion. Wei J; Waithman J; Lata R; Mifsud NA; Cebon J; Kay T; Smyth MJ; Sadler AJ; Chen W J Immunol; 2010 Nov; 185(10):6013-22. PubMed ID: 20956347 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes. Fu C; Peng P; Loschko J; Feng L; Pham P; Cui W; Lee KP; Krug AB; Jiang A Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23730-23741. PubMed ID: 32879009 [TBL] [Abstract][Full Text] [Related]
8. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032 [TBL] [Abstract][Full Text] [Related]
11. Type I IFN Activating Type I Dendritic Cells for Antitumor Immunity. Liang Y; Hannan R; Fu YX Clin Cancer Res; 2021 Jul; 27(14):3818-3824. PubMed ID: 33692027 [TBL] [Abstract][Full Text] [Related]
12. Intestinal Batf3-dependent dendritic cells are required for optimal antiviral T-cell responses in adult and neonatal mice. Sun T; Rojas OL; Li C; Ward LA; Philpott DJ; Gommerman JL Mucosal Immunol; 2017 May; 10(3):775-788. PubMed ID: 27600308 [TBL] [Abstract][Full Text] [Related]
13. NAIP-NLRC4 Inflammasomes Coordinate Intestinal Epithelial Cell Expulsion with Eicosanoid and IL-18 Release via Activation of Caspase-1 and -8. Rauch I; Deets KA; Ji DX; von Moltke J; Tenthorey JL; Lee AY; Philip NH; Ayres JS; Brodsky IE; Gronert K; Vance RE Immunity; 2017 Apr; 46(4):649-659. PubMed ID: 28410991 [TBL] [Abstract][Full Text] [Related]
14. Effective Priming of Herpes Simplex Virus-Specific CD8 Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130 [TBL] [Abstract][Full Text] [Related]
15. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen. Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656 [TBL] [Abstract][Full Text] [Related]
16. Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8 Murata Y; Kawashima K; Sheikh K; Tanaka Y; Isogawa M J Virol; 2018 Nov; 92(21):. PubMed ID: 30089700 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells. Katakam AK; Brightbill H; Franci C; Kung C; Nunez V; Jones C; Peng I; Jeet S; Wu LC; Mellman I; Delamarre L; Austin CD Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14664-9. PubMed ID: 26561586 [TBL] [Abstract][Full Text] [Related]
18. Cross-presentation of dead-cell-associated antigens by DNGR-1 Balam S; Kesselring R; Eggenhofer E; Blaimer S; Evert K; Evert M; Schlitt HJ; Geissler EK; van Blijswijk J; Lee S; Reis e Sousa C; Brunner SM; Fichtner-Feigl S Eur J Immunol; 2020 Dec; 50(12):2041-2054. PubMed ID: 32640051 [TBL] [Abstract][Full Text] [Related]
19. Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes. Reinicke AT; Omilusik KD; Basha G; Jefferies WA PLoS One; 2009 Oct; 4(10):e7210. PubMed ID: 19806187 [TBL] [Abstract][Full Text] [Related]
20. PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8 Chaib M; Sipe LM; Yarbro JR; Bohm MS; Counts BR; Tanveer U; Pingili AK; Daria D; Marion TN; Carson JA; Thomas PG; Makowski L Cancer Lett; 2022 Apr; 531():98-108. PubMed ID: 35074498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]